(44.192.10.166) 您好!臺灣時間:2021/03/05 09:12
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果

詳目顯示:::

我願授權國圖
: 
twitterline
研究生:陳韻文
研究生(外文):Yun-Wen Chen
論文名稱:配戴角膜塑型鏡片合併使用極低濃度阿托平眼藥水對於高危險近視進展孩童的影響
論文名稱(外文):The Effects of Combined Orthokeratology with Low Concentration Atropine Treatment in Myopic Children at Risk of Fast Progression
指導教授:許勤許勤引用關係
指導教授(外文):Chin Hsu
口試委員:吳佩昌吳文權
口試委員(外文):Pei-Chang WuWen-Chuan Wu
學位類別:碩士
校院名稱:高雄醫學大學
系所名稱:臨床醫學研究所碩士班
學門:醫藥衛生學門
學類:醫學學類
論文種類:學術論文
論文出版年:2018
畢業學年度:106
語文別:中文
論文頁數:48
中文關鍵詞:近視角膜塑形片阿托平
外文關鍵詞:myopiaorthokeratologyatropine
相關次數:
  • 被引用被引用:0
  • 點閱點閱:44
  • 評分評分:系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔系統版面圖檔
  • 下載下載:7
  • 收藏至我的研究室書目清單書目收藏:0
研究背景
近視是孩童區屈光異常中常見的一個疾病。其成因分爲軸性的近視以及非軸性的近視,前者因眼軸不斷增長導致影像無法清晰投射於視網膜之上,也是兒童近視的主要成因。近視是一種疾病,與許多嚴重的併發症相關,如視網膜剝離、近視性黃斑新生血管出血、近視性黃斑退化、青光眼等,防治及控制兒童近視乃是一重要議題。控制近視的治療方法有許多,本文主要探討極低濃度阿托平(0.01%)眼藥水以及角膜塑形鏡片合併使用對於兒童近視控制的效果。阿托平眼藥水已證實為有效控制近視的方法,而角膜塑形鏡片也是一有效控制近視的治療工具,其作用機轉的假說為鏡片造成的週邊近視性離焦,來延緩眼軸的增長。然而,合併使用阿托平眼藥水及角膜塑形鏡片的治療效果則未有共識,本文主要欲探討合併兩種治療方式於近視孩童的控制成效。
研究方法
此研究乃回溯性統計及分析近視孩童於2009年至2015年使用阿托平藥水(0.01%)合併角膜塑形鏡片或單純使用角膜塑形鏡片的治療效果。與家長討論孩童平時的活動之後,若患童被評估為高危險近視進展的族群,則提供極低濃度阿托平眼藥水(0.01%)合併角膜塑形鏡片的治療方法。主要評估治療成效的方法是測量患童的眼軸長度。
結果
總共收錄47位孩童,47顆眼睛,來自22位男孩及25位女孩。平均屈光異常的球面當量為−3.68 ± 1.41 D,追蹤平均時間為3.93 ± 1.18年,每位孩童的追蹤時間皆大於兩年。患童的平均年紀為10.60 ± 1.62歲。在47位患童中,32位(68%)接受了極低濃度阿托平眼藥水(0.01%)合併角膜塑形鏡片的治療,25位(32%)接受了角膜塑形鏡片的治療,兩組每年平均增長的眼軸長沒有顯著差別(p = 0.977, 統計方法:GEE),兩組也均無報告治療副作用。
結論
針對高危險近視進展的孩童,使用合併極低濃度阿托平(0.01%)眼藥水合併角膜塑形鏡片治療方法其效果與一般近視孩童單獨使用角膜塑形鏡片並無差異。仍需其他研究來證實阿托平藥水與角膜塑形鏡片治療的相互影響關係。
Background and Objectives
Myopia is among the most common refractive errors that affect children. It is related with severe complications such as retinal detachment, myopic macular degenerations, and glaucoma, which were sight-threatening. Slowing the progression of myopia has become a considerable concern for parents of myopic children. The purpose of this study is to evaluate the combined effects of low concentration (0.01%) atropine and orthokeratology (OK) in myopic children at risk of fast progression.
Material and Methods
The retrospective study included children aged 9-15 years with a spherical equivalent (SE) refraction of −3.68 ± 1.41 D and astigmatism of −2.50 D or less. They were assigned to two treatment protocols, OK or OK with low concentration atropine (0.01%), based on the patient’s assessment. After consulting with parents, myopic children at risk of fast progression generally were applied combination therapy. Their axial length (AXL) was measured and compared.
Results
Forty-seven eyes from 47 children (22 boys and 25 girls) with myopia (SE, −3.68 ± 1.41 D) undergoing treatment with OK or OK with low concentration atropine, from 2009–2015, with at least 2 years follow-up were enrolled. The average follow-up period and patient’s mean age were 3.93 ± 1.18 years and 10.60 ± 1.62 years, respectively. Thirty-two children (68.09%, the study group) received the combination therapy, whereas the other 15 (31.91%, the control group) received only OK. Annual AXL elongation showed no significant differences between the two groups (p = 0.977 by GEE). There were no significant adverse effects in either group.
Conclusions
Myopic children at risk of fast progression with combination therapy did not show significant difference from single therapy of OK treatment in myopic children, Further studies should be designed to clarify the additional effect of atropine toward OK.
中文摘要……………………………………………………….3
英文摘要 Abstract……………………………………………5
誌謝……………………………………………………………7
縮寫 Abbreviates……………………………………………...8
第一章前言 Introduction……………………………………..9
第二章材料與方法 Materials and methods………………….12
第三章結果 Results ………………………………………….15
第四章討論 Discussion………………………………………19
第五章結論 Conclusion……………………………………...21
英文論文 Manuscript………………………………………...22
參考文獻 References…………………………………………33
附表 Tables…………………………………………..………41
附圖 Figures…………………………………………………44
附錄 個人簡介……………………………………………….46
1.Swarbrick HA, Alharbi A, Watt K et al (2015) Myopia control during orthokeratology lens wear in children using a novel study design. Ophthalmology 122:620-630.
2.Tokoro A, Suzuki K (1969) Changes in ocular refractive components and development of myopia during seven years. Jpn J Ophthalmol 13:27-34.
3.Fledelius HC (1982) Ophthalmic changes from age of 10 to 18 years. A longitudinal study of sequels to low birth weight. III. Ultrasound oculometry and keratometry of anterior eye segment. Acta Ophthalmol (Copenh) 60:393-402.
4.Fledelius HC (1982) Ophthalmic changes from age of 10 to 18 years. A longitudinal study of sequels to low birth weight. IV. Ultrasound oculometry of vitreous and axial length. Acta Ophthalmol (Copenh) 60:403-411.
5.Hosaka A (1988) The growth of the eye and its components. Japanese studies. Acta Ophthalmol Suppl 185:65-68.
6.Kakita T, Hiraoka T, Oshika T (2011) Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci 52:2170-2174.
7.Dandona R, Dandona L (2001) Refractive error blindness. Bull World Health Organ 79:237-243.
8.McCarty CA (2006) Uncorrected refractive error. Br J Ophthalmol 90:521-522.
9.Bourne RR, Dineen BP, Ali SM et al (2004) Prevalence of refractive error in Bangladeshi adults: results of the National Blindness and Low Vision Survey of Bangladesh. Ophthalmology 111:1150-1160.
10.Wong TY, LoonSC, Saw SM (2006) The epidemiology of age related eye diseases in Asia. Br J Ophthalmol 90:506-511.
11.Goldschmidt E (1988) Ocular morbidity in myopia. Acta Ophthalmol Suppl 185: 86-87.
12.No authors listed (1993) Risk factors for idiopathic rhegmatogenous retinal detachment. The Eye Disease Case-Control Study Group. Am J Epidemiol 137:749-757.
13.Mitchell P, Hourihan F, Sandbach J et al (1999) The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 106:2010-2015.
14.Saw SM, Gazzard G, Sgih-Yen EC et al (2005) Myopia and associated pathological complications. Ophthalmic Physiol Opt 25:381-391.
15.Walline JJ (2016) Myopia Control: A Review. Eye Contact Lens 42:3-8.
16.Morgan IG, Ohno-Matsui K, Saw SM (2012) Myopia. Lancet 379:1739-1748.
17.Ikuno Y, Jo Y, Hamasaki T et al (2010) Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol Vis Sci 51:3721-3725.
18.Hsu WM, Cheng CY,Liu JH et al (2004) Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 111:62-69.
19.Iwase A, Araie M, Tomidokoro A et al (2006) Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 113:1354-1362.
20.Swabrick HA (2006) Orthokeratology review and update. Clin Exp Optom 89:124-143.
21.Si JK, Tang K, Bi HS et al (2015) Orthokeratology for myopia control: a meta-analysis. Optom Vis Sci 92:252-257.
22.Sun Y, Xu F, Zhang T et al (2015) Orthokeratology to control myopia progression: a meta-analysis. PLoS One 10:e0124535.
23.He M, Du Y, Liu Q et al (2016) Effects of orthokeratology on the progression of low to moderate myopia in Chinese children. BMC Ophthalmol 16:126.
24.Reinstein DZ, Gobbe M, Archer TJ et al (2009) Epithelial, stromal, and corneal pachymetry changes during orthokeratology. Optom Vis Sci 86: E1006-14.
25.Lin HJ, Wan L, Tsai FJ et al (2014) Overnight orthokeratology is comparable with atropine in controlling myopia. BMC Ophthalmol 14:40.
26.Zhong X, Chen X, Xie RZ et al (2009) Differences between overnight and long-term wear of orthokeratology contact lenses in corneal contour, thickness, and cell density. Cornea 28:271-279.
27.Smith EL 3rd, Kee CS, Ramamirtham R et al (2005) Peripheral vision can influence eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci 46:3965-3972.
28.Chua WH, Balakrishnan V, Chan YH et al (2006) Atropine for the treatment of childhood myopia. Ophthalmology 113:2285-2291.
29.Song YY, Wang H, Wang BS et al (2011) Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials. J Ocul Pharmacol Ther 27:361-368.
30.Tay SA, Farzavandi S, Tan D (2017) Interventions to Reduce Myopia Progression in Children. Strabismus 25:23-32.
31.Wu PC, Yang YH, Fang PC (2011) The long-term results of using low-concentration atropine eye drops for controlling myopia progression in schoolchildren. J Ocul Pharmacol Ther 27:461-466.
32.Chia A, Chua WH, CheungYB et al (2012) Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology 119:347-354.
33.Leo SW, Scientic Breau of World Society of Paediatric Ophthalmology and Strabismus (WSPOS) (2017) Current approaches to myopia control. Curr Opin Ophthalmol 28:267-275.
34.Cooper J, Schulman E, Jamal N (2012) Current status on the development and treatment of myopia. Optometry 83:179-199.
35.Saw SM, Wu HM, Seet B et al (2001) Academic achievement, close up work parameters, and myopia in Singapore military conscripts. Br J Ophthalmol 85:855-860.
36.Tan GJ, Ng YP, Lim YC et al (2000) Cross-sectional study of near-work and myopia in kindergarten children in Singapore. Ann Acad Med Singapore 29:740-744.
37.Lin LL, Shih YF, Lee YC et al (1996) Changes in ocular refraction and its components among medical students--a 5-year longitudinal study. Optom Vis Sci 73:495-498.
38.Huang HM, Chang DS, Wu PC (2015) The Association between Near Work Activities and Myopia in Children-A Systematic Review and Meta-Analysis. PLoS One 10:e0140419.
39.Jung SK, Lee JH, Kakizaki H et al (2012) Prevalence of myopia and its association with body stature and educational level in 19-year-old male conscripts in seoul, South Korea. Invest Ophthalmol Vis Sci 53:5579-5583.
40.Sun J, Zhou J, Zhao P et al (2012) High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai. Invest Ophthalmol Vis Sci 53:7504-7509.
41.Pruett RC (1998) Complications associated with posterior staphyloma. Curr Opin Ophthalmol 9:16-22.
42.Saw SM (2006) How blinding is pathological myopia? Br J Ophthalmol 90:525-526.
43.Saw SM, Shih-Yen EC, Koh A et al (2002) Interventions to retard myopia progression in children: an evidence-based update. Ophthalmology 109:415-421; discussion 422-424; quiz 425-6, 443.
44.Duncan G, Collison DJ (2003) Role of the non-neuronal cholinergic system in the eye: a review. Life Sci 72:2013-2019.
45.Cho P, Cheung SW, Edwards M (2005) The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res 30:71-80.
46.Walline JJ, Jones LA, Sinnott LT (2009) Corneal reshaping and myopia progression. Br J Ophthalmol 93:1181-1185.
47.Santodomingo-Rubido J, Villa-Collar C, Gilmartin B et al (2012) Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci 53:5060-5065.
48.Swarbrick HA, Alharbi A, Watt K et al (2015) Myopia control during orthokeratology lens wear in children using a novel study design. Ophthalmology 122:620-630.
49.Kang P, Swarbrick H (2011) Peripheral refraction in myopic children wearing orthokeratology and gas-permeable lenses. Optom Vis Sci 88:476-482.
50.Chen Z, Niu L, Xue F et al (2012) Impact of pupil diameter on axial growth in orthokeratology. Optom Vis Sci 89:1636-1640.
51.Loughman J, Flitcroft DI (2016) The acceptability and visual impact of 0.01% atropine in a Caucasian population. Br J Ophthalmol 100:1525-1529.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
系統版面圖檔 系統版面圖檔